ACRIVASTINE VERSUS CLEMASTINE IN THE TREATMENT OF CHRONIC IDIOPATHIC URTICARIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

被引：19
作者：
JUHLIN, L
GIBSON, JR
HARVEY, SG
HUSON, LW
机构：
[1] WELLCOME RES LABS,LANGLEY COURT,BECKENHAM BR3 3BS,KENT,ENGLAND
[2] UNIV UPPSALA,SCH MED,DEPT DERMATOL,S-75105 UPPSALA,SWEDEN
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 1987年 / 26卷 / 10期
关键词：
D O I：
10.1111/j.1365-4362.1987.tb02275.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：653 / 654
页数：2
相关论文
共 50 条
  • [31] Theophylline as 'add-on' therapy to cetirizine in patients with chronic idiopathic urticaria - A randomized, double-blind, placebo-controlled pilot study
    Kalogeromitros, D
    Kempuraj, D
    Katsarou-Katsari, A
    Makris, M
    Gregoriou, S
    Papaliodis, D
    Theoharides, TC
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2006, 139 (03) : 258 - 264
  • [32] Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study
    Ring, J
    Hein, R
    Gauger, A
    Bronsky, E
    Miller, B
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2001, 40 (01) : 72 - 76
  • [33] TREATMENT OF CHRONIC-SCHIZOPHRENIA WITH CYPROHEPTADINE - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    SILVER, H
    BLACKER, M
    WELLER, MPI
    LERER, B
    BIOLOGICAL PSYCHIATRY, 1991, 30 (05) : 523 - 525
  • [34] A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers
    Arosio, E
    Ferrari, G
    Santoro, L
    Gianese, F
    Coccheri, S
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2001, 22 (04) : 365 - 372
  • [35] A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis
    Carter, Melody C.
    Maric, Irina
    Brittain, Erica H.
    Bai, Yun
    Lumbard, Keith
    Bolan, Hyejeong
    Cantave, Daly
    Scott, Linda M.
    Metcalfe, Dean D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (03) : 1004 - +
  • [36] Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients
    Jorg, L.
    Pecaric-Petkovic, T.
    Reichenbach, S.
    Coslovsky, M.
    Stalder, O.
    Pichler, W.
    Hausmann, O.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (02) : 196 - 204
  • [37] Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial
    Monroe, E
    Finn, A
    Patel, P
    Guerrero, R
    Ratner, P
    Bernstein, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (04) : 535 - 541
  • [38] A COMPARISON OF ACRIVASTINE VERSUS CHLORPHENIRAMINE IN THE TREATMENT OF CHRONIC IDIOPATHIC URTICARIA
    GALE, AE
    HARVEY, SG
    CALTHROP, JG
    GIBSON, JR
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1989, 17 : B25 - B27
  • [39] Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults
    Kalis, B
    DRUGS, 1996, 52 : 30 - 34
  • [40] The safety and efficacy of Omalizumab in chronic idiopathic/dpontaneous urticaria: Results from a phase iii randomized, double-blind, placebo-controlled study
    Katelaris, C. H.
    Maurer, M.
    Staubach, P.
    Ashby, M.
    Canvin, J.
    Ledford, D.
    Kaplan, A.
    Jakob, T.
    Rosen, K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2014, 55 : 37 - 37
12345